İnfrapatellar Yağ Yastığı ve Diz Eklemi Osteoartriti

Yazarlar

Sercan Çapkın
https://orcid.org/0000-0001-6957-5927

Özet

İnfrapatellar yağ yastığı (İPYY), diz ekleminde hem biyomekanik hem de endokrinolojik rollere sahip olan ve patogenezi henüz tam olarak anlaşılamamış diz eklemi osteoartritinde (OA) anahtar rol oynayan aktif bir dokudur. Anatomik olarak eklem içi ancak ekstrasinovyal yerleşimli olan İPYY; zengin bir vasküler ağa ve Substans P ile CGRP pozitif sinir liflerinden oluşan yoğun bir duyusal inervasyona sahiptir; bu özellikleri nedeniyle ön diz ağrısının ve nörojenik inflamasyonun birincil kaynaklarından biri olarak kabul edilir. Obezite ve yaşlanma süreçlerinde metabolik ve hücresel düzeyde tetiklenen İPYY; IL-1β, IL-6, TNF-α gibi pro-inflamatuar sitokinler ile leptin ve adiponektin gibi adipokinleri doğrudan sinovyal sıvıya salgılayarak eklem kıkırdağı yıkımını, subkondral kemik sklerozunu, menisküs ve bağ dejenerasyonunu sinerjik olarak hızlandırır. Buna karşılık İPYY, yüksek proliferasyon ve üstün kondrojenik farklılaşma kapasitesine sahip zengin mezenkimal kök hücre (MKH) içeriğiyle, rejeneratif tıp çalışmalarında fokal kıkırdak hasarlarının hücresel tedavisinde güçlü ve kolay erişilebilir anabolik bir kaynak sunar. Total diz artroplastisi (TDA) cerrahisinde ise görüş alanını artırmak amacıyla İPYY'nin eksize edilmesi veya korunması konusu halen tartışmalıdır; literatürde eksizyonun diz önü ağrısı, patellar tendon kısalması ve patella vaskülarizasyonu üzerindeki etkilerine dair çelişkili klinik sonuçlar bulunmakla birlikte, eklem hareket açıklığı ve fonksiyonel skorlarda gruplar arasında genellikle anlamlı bir fark saptanmamıştır. Sonuç olarak İPYY, basit bir mekanik koruyucu yastık olmanın ötesinde, diz osteoartritinin hem ilerlemesinde hem de hücresel tedavisinde çift yönlü işlevi olan metabolik bir organdır.

The infrapatellar fat pad (IPFP) is an active tissue that plays a key role in knee joint osteoarthritis (OA), a disease whose pathogenesis is not yet fully understood, and possesses both biomechanical and endocrinological roles in the knee joint. Anatomically intracapsular but extrasynovial, the IPFP has a rich vascular network and dense sensory innervation consisting of Substance P and CGRP positive nerve fibers; due to these features, it is considered one of the primary sources of anterior knee pain and neurogenic inflammation. Triggered at the metabolic and cellular level during obesity and aging processes, the IPFP secretes pro-inflammatory cytokines such as IL-1β, IL-6, TNF-α, and adipokines like leptin and adiponectin directly into the synovial fluid, synergistically accelerating articular cartilage destruction, subchondral bone sclerosis, and meniscus and ligament degeneration. Conversely, with its rich mesenchymal stem cell (MSC) content having high proliferation and superior chondrogenic differentiation capacity, the IPFP offers a potent and easily accessible anabolic source for the cellular treatment of focal cartilage defects in regenerative medicine studies. In total knee arthroplasty (TKA) surgery, the excision or preservation of the IPFP to increase the surgical field is still controversial; although the literature presents conflicting clinical results regarding the effects of excision on anterior knee pain, patellar tendon shortening, and patellar vascularization, no significant difference is generally detected between the groups in terms of range of motion and functional scores. In conclusion, beyond being a simple mechanical protective cushion, the IPFP is a metabolic organ with a dual function in both the progression and cellular treatment of knee osteoarthritis.

Referanslar

Cui A, Li H, Wang D, et al. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. eClinicalMedicine. 2020;29–30:100587.

Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis & Rheumatology. 2012;64(6):1697–1707.

Kumavat R, Kumar V, Malhotra R, et al. Biomarkers of Joint Damage in Osteoarthritis: Current Status and Future Directions. Mediators of Inflammation. 2021;2021:5574582.

Safiri S, Kolahi AA, Hoy D, et al. Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017. Annals of the Rheumatic Diseases. 2019;78(11):1463–1471.

Yasuda T. Cartilage destruction by matrix degradation products. Modern Rheumatology. 2006;16(4):197–205.

Bobinac D, Spanjol J, Zoricic S, et al. Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans. Bone. 2003;32(3):284–290.

Favero M, El-Hadi H, Belluzzi E, et al. Infrapatellar fat pad features in osteoarthritis: a histopathological and molecular study. Rheumatology (Oxford). 2017;56(10):1784–1793.

Ioan-Facsinay A, Kloppenburg M. An emerging player in knee osteoarthritis: the infrapatellar fat pad. Arthritis Research & Therapy. 2013;15(6):225.

Distel E, Cadoudal T, Durant S, et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis & Rheumatology. 2009;60(11):3374–3377.

Paduszynski W, Jeskiewicz M, Uchanski P, et al. Hoffa's Fat Pad Abnormality in the Development of Knee Osteoarthritis. Advances in Experimental Medicine and Biology. 2019;1039:95–102.

Greif DN, Kouroupis D, Murdock CJ, et al. Infrapatellar Fat Pad/Synovium Complex in Early-Stage Knee Osteoarthritis: Potential New Target and Source of Therapeutic Mesenchymal Stem/Stromal Cells. Frontiers in Bioengineering and Biotechnology. 2020;8:860.

Robinson WH, Lepus CM, Wang Q, et al. Low‐grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nature Reviews Rheumatology. 2016;12:580–592.

Klein‐Wieringa IR, Kloppenburg M, Bastiaansen‐Jenniskens YM, et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Annals of Rheumatic Diseases. 2011;70:851–857.

Eymard F, Pigenet A, Citadelle D, et al. Knee and hip intra‐articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis. Annals of Rheumatic Diseases. 2017;76:1142–1148.

Hoffa A.The influence of adipose tissue with regard to pathology of the knee joint. Journal of the American Medical Association. 1904;42:795–796.

Gallagher J, Tierney P, Murray P, O’Brien M. The infrapatellar fat pad: anatomy and clinical correlations. Knee Surgery, Sports Traumatolology, Arthrosccopy. 2005;13(4):268–272.

Woodley SJ, Latimer CP, Meikle GR, et al. Articularis genus: an anatomic and MRI study in cadavers. Journal of Bone and Joint Surgery (Am). 2012;94(1):59–67.

Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis and Cartilage. 2010;18(7):876–882.

Macchi V, Stocco E, Stecco C, et al. The infrapatellar fat pad and the synovial membrane: an anatomo-functional unit. Journal of Anatomy. 2018;233(2):146–154.

Diepold J, Ruhdorfer A, Dannhauer T, et al. Sex-differences of the healthy infra-patellar (Hoffa) fat pad in relation to intermuscular and subcutaneous fat content--data from the Osteoarthritis Initiative. Annals of Anatomy. 2015;200:30–36.

Burda B, Steidle-Kloc E, Dannhauer T, et al. Variance in infra-patellar fat pad volume: Does the body mass index matter?-Data from osteoarthritis initiative participants without symptoms or signs of knee disease. Annals of Anatomy. 2017;213:19–24.

Dragoo JL, Johnson C, McConnell J. Evaluation and treatment of disorders of the infrapatellar fat pad. Sports Medicine. 2012;42(1):51–67.

Sun C, Zhang X, Lee WG, et al. Infrapatellar fat pad resection or preservation during total knee arthroplasty: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research. 2020;15(1):297.

Nemschak G, Pretterklieber ML. The patellar arterial supply via the infrapatellar fat pad (of Hoffa): a combined anatomical and angiographical analysis. Anatomy Research International. 2012;2012:713838.

Kohn D, Deiler S, Rudert M. Arterial blood supply of the infrapatellar fat pad. Anatomy and clinical consequences. Archives of Orthopaedic Trauma Surgery. 1995;114(2):72–75.

Kennedy JC, Alexander IJ, Hayes KC. Nerve supply of the human knee and its functional importance. American Journal of Sports Medicine. 1982;10(6):329–335.

Bennell K, Hodges P, Mellor R, et al. The nature of anterior knee pain following injection of hypertonic saline into the infrapatellar fat pad. Journal of Orthopaedic Research. 2004;22(1):116–121.

Gardner E. The innervation of the knee joint. Anatomical Record. 1948;101:109–130.

Bohnsack M, Meier F, Walter GF, et al. Distribution of substance-P nerves inside the infrapatellar fat pad and the adjacent synovial tissue: a neurohistological approach to anterior knee pain syndrome. Archives of Orthopaedic and Trauma Surgery. 2005;125(9):592–597.

Eymard F, Chevalier X. Inflammation of the infrapatellar fat pad. Joint Bone Spine. 2016;83(4):389–393.

Fontanella CG, Belluzzi E, Rossato M, et al. Quantitative MRI analysis of infrapatellar and suprapatellar fat pads in normal controls, moderate and end-stage osteoarthritis. Annals of Anatomy. 2019;221:108–114.

Walsh DA, Mapp PI, Kelly S. Calcitonin gene-related peptide in the joint: contributions to pain and inflammation. British Journal of Clinical Pharmacology. 2015;80(5):965–978.

Lehner B, Koeck FX, Capellino S, et al. Preponderance of sensory versus sympathetic nerve fibers and increased cellularity in the infrapatellar fat pad in anterior knee pain patients after primary arthroplasty. Journal of Orthopaedic Research. 2008;26(3):342–350.

Leese J, Davies DC. An investigation of the anatomy of the infrapatellar fat pad and its possible involvement in anterior pain syndrome: a cadaveric study. Journal of Anatomy. 2020;237(1):20–28.

Belluzzi E, El Hadi H, Granzotto M, et al. Systemic and Local Adipose Tissue in Knee Osteoarthritis. Journal of Cellular Physiology. 2017;232(8):1971–1978.

Zeng N, Yan ZP, Chen XY, et al. Infrapatellar fat pad and knee osteoarthritis. Aging and Disease. 2020;11(5):1317–1328.

Davies DV, White JE. The structure and weight of synovial fat pads. Journal of Anatomy. 1961;95(Pt 1):30–37.

Macchi V, Porzionato A, Sarasin G, Petrelli L, Guidolin D, Rossato M, Fontanella CG, Natali A, De Caro R. The Infrapatellar Adipose Body: A Histotopographic Study. Cells Tissues Organs. 2016;201(3):220–231.

Jiang LF, Fang JH, Wu LD. Role of infrapatellar fat pad in pathological process of knee osteoarthritis: future applications in treatment. World Journal of Clinical Cases. 2019;7:2134–2142.

Sellam J, Berenbaum F. Is osteoarthritis a metabolic disease? Joint Bone Spine. 2013;80(6):568–573.

Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. American Journal of Clinical Nutrition. 2006;83(2):461–465.

Da Costa LA, Arora P, García-Bailo B, et al. The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2012;5:347–355.

Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology. 2010;316(2):129–139.

Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism. 2004;89(6): 2548–2556.

Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators of İnflammation. 2010;2010:802078.

Bravo B, Guisasola MC, Vaquero J, et al. Gene expression, protein profiling, and chemotactic activity of infrapatellar fat pad mesenchymal stem cells in pathologies of the knee joint. Journal of Cellular Physiology. 2019;234(10):18917–18927.

de Boer TN, van Spil WE, Huisman AM, et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis and Cartilage. 2012;20(8):846–853.

Beekhuizen M, Gierman LM, van Spil WE, et al. An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid. Osteoarthritis and Cartilage. 2013;21(7):918–922.

Dumond H, Presle N, Terlain B, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis & Rheumatology. 2003;48(11):3118–3129.

Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Current Medical Chemistry. 2007;14(10):1095–1100.

Poonpet T, Honsawek S. Adipokines: Biomarkers for osteoarthritis? World Journal of Orthopedics. 2014;5(3):319–327.

Bao JP, Chen WP, Feng J, et al. Leptin plays a catabolic role on articular cartilage. Molecular Biology Reports. 2010;37(7):3265–3272.

Maor G, Rochwerger M, Segev Y, et al. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. Journal of Bone and Mineral Research. 2002;17(6):1034–1043.

Bao JP, Jiang LF, Chen WP, et al. Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. International Journal of Clinical and Experimental Medicine. 2014;7(10):3447–3453.

Matarese G, Leiter EH, La Cava A. Leptin in autoimmunity: many questions, some answers. Tissue Antigens. 2007;70(2):87–95.

de Jong AJ, Klein-Wieringa IR, Andersen SN, et al. Lack of high BMI-related features in adipocytes and inflammatory cells in the infrapatellar fat pad (IFP). Arthritis Research & Therapy. 2017;19(1):186.

Tang Q, Hu ZC, Shen LY, et al. Association of osteoarthritis and circulating adiponectin levels: a systematic review and meta-analysis. Lipids in Health and Disease. 2018;17(1):189.

Ibrahim SM, Hamdy MS, Amer N. Plasma and synovial fluid adipocytokines in patients with rheumatoid arthritis and osteoarthritis. Egyptian Journal of Immunology. 2008;15:159–170.

Tan W, Wang F, Zhang M, et al. High adiponectin and adiponectin receptor 1 expression in synovial fluids and synovial tissues of patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 2009;38:420–427.

Koskinen A, Juslin S, Nieminen R, et al. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Research & Therapy. 2011;13:R184.

Laurberg TB, Frystyk J, Ellingsen T, et al. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. Journal of Rheumatology. 2009;36(9):1885–1891.

Francin PJ, Abot A, Guillaume C, et al. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthritis and Cartilage. 2014;22(3):519–526.

Honsawek S, Chayanupatkul M. Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity. Archives of Medical Research. 2010;41(8):593–598.

Gandhi R, Takahashi M, Smith H, et al. The synovial fluid adiponectin-leptin ratio predicts pain with knee osteoarthritis. Clinical Rheumatology. 2010;29(11):1223–1228.

Bas S, Finckh A, Puskas GJ, et al. Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. International Orthopaedics. 2014;38(12):2577–2583.

Han W, Cai S, Liu Z, et al. Infrapatellar fat pad in the knee: is local fat good or bad for knee osteoarthritis? Arthritis Research & Therapy. 2014;16:R145.

Teichtahl AJ, Wulidasari E, Brady SR, et al. A large infrapatellar fat pad protects against knee pain and lateral tibial cartilage volume loss. Arthritis Research & Therapy. 2015;17:318.

Cai J, Xu J, Wang K, et al. Association between infrapatellar fat pad volume and knee structural changes in patients with knee osteoarthritis. Journal of Rheumatology. 2015;42(10):1878–1884.

Zhou S, Maleitzke T, Geissler S, et al. Source and hub of inflammation: The infrapatellar fat pad and its interactions with articular tissues during knee osteoarthritis. Journal of Orthopaedic Research. 2022;40(7):1492–1504.

Gandhi R, Takahashi M, Virtanen C, et al. Microarray analysis of the infrapatellar fat pad in knee osteoarthritis: relationship with joint inflammation. Journal of Rheumatology. 2011;38(9):1966–1972.

Weinberg JB, Fermor B, Guilak F. Nitric oxide synthase and cyclooxygenase interactions in cartilage and meniscus: relationships to joint physiology, arthritis, and tissue repair. SubCellular Biochemistry. 2007;42:31–62.

Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clinical Orthopaedics and Related Research. 2004(427 Suppl:S37–46.

Belluzzi E, Macchi V, Fontanella CG, et al. Infrapatellar fat Pad gene expression and protein production in patients with and without osteoarthritis. International Journal of Molecular Science. 2020;21(17):6016.

Lago R, Gomez R, Otero M, et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro‐inflammatory cytokines in chondrocytes. Osteoarthritis and Cartilage. 2008;16(9):1101–1109.

Chen TH, Chen L, Hsieh MS, et al. Evidence for a protective role for adiponectin in osteoarthritis. Biochimica Biophysica Acta. 2006;1762(8):711–718.

Simopoulou T, Malizos KN, Iliopoulos D, et al. Differential expression of leptin and leptin's receptor isoform (Ob‐Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis and Cartilage. 2007;15(8):872–883.

Vuolteenaho K, Koskinen A, Kukkonen M, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage‐‐mediator role of NO in leptin‐induced PGE2, IL‐6, and IL‐8 production. Mediators of Inflammation. 2009;2009:345838.

Staikos C, Ververidis A, Drosos G, et al. The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis. Rheumatology (Oxford). 2013;52(6):1077–1083.

Wang L, Shao YY, Ballock RT. Leptin synergizes with thyroid hormone signaling in promoting growth plate chondrocyte proliferation and terminal differentiation in vitro. Bone. 2011;48(5):1022–1027.

Xie C, Chen Q. Adipokines: new therapeutic target for osteoarthritis? Current Rheumatology Reports. 2019;21(12):71.

Ding DC, Wu KC, Chou HL, et al. Human infrapatellar fat Pad‐derived stromal cells have more potent differentiation capacity than other mesenchymal cells and can be enhanced by hyaluronan. Cell Transplantation. 2015;24(7):1221–1232.

Bastiaansen‐Jenniskens YM, Clockaerts S, Feijt C, et al. Infrapatellar fat pad of patients with end‐stage osteoarthritis inhibits catabolic mediators in cartilage. Annals of Rheumatic Diseases. 2012;71(2):288–294.

Donell S. Subchondral bone remodelling in osteoarthritis. EFORT Open Revews. 2019;4(6):221–229.

Hu W, Chen Y, Dou C, Dong S. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Annals of Rheumatic Diseases. 2020;80(4):413–422.

Blom AB, van Lent PL, Holthuysen AE, et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis and Cartilage. 2004;12(8):627–635.

van Lent PL, Blom AB, van der Kraan P, et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta‐mediated osteophyte formation. Arthritis & Rheumatology. 2004;50(1):103–111.

Wu CL, Harasymowicz NS, Klimak MA, et al. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis and Cartilage. 2020;28(5):544–554.

Scotece M, Conde J, Vuolteenaho K, et al. Adipokines as drug targets in joint and bone disease. Drug Discovery Today. 2014;19(3):241–258.

Motyl KJ, Rosen CJ. Understanding leptin‐dependent regulation of skeletal homeostasis. Biochimie. 2012;94(10):2089–2096.

Wang Y, Zhang X, Shao J, et al. Adiponectin regulates BMSC osteogenic differentiation and osteogenesis through the Wnt/beta‐catenin pathway. Scientific Reports. 2017;7(1):3652.

Liu X, Chen T, Wu Y, et al. Role and mechanism of PTEN in adiponectin‐induced osteogenesis in human bone marrow mesenchymal stem cells. Biochemical Biophysical Research Communications. 2017;483(1):712–717.

Chen T, Wu Y, Lu H, et al. Adiponectin enhances osteogenic differentiation in human adipose‐derived stem cells by activating the APPL1‐AMPK signaling pathway. Biochemical Biophysical Research Communications. 2015;461(2):237–242.

Wu Y, Tu Q, Valverde P, et al. Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. American Journal of Physiology-Endocrinology and Metabolism. 2014;306(12):E1418–1430.

Mutabaruka MS, Aoulad Aissa M, Delalandre A, et al. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Research & Therapy. 2010;12(1):R20.

Reid IR. Relationships between fat and bone. Osteoporosis International. 2008;19(5):595–606.

Berry PA, Jones SW, Cicuttini FM, et al. Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis. Arthritis & Rheumatology. 2011;63(3):700–707.

Xie H, Tang SY, Luo XH, et al. Insulin‐like effects of visfatin on human osteoblasts. Calcified Tissue International. 2007;80(3):201–210.

Draghi F, Ferrozzi G, Urciuoli L, et al. Hoffa's fat pad abnormalities, knee pain and magnetic resonance imaging in daily practice. Insights into Imaging. 2016;7(3):373–383.

Nishimuta JF, Bendernagel MF, Levenston ME. Co‐culture with infrapatellar fat pad differentially stimulates proteoglycan synthesis and accumulation in cartilage and meniscus tissues. Connective Tissue Research. 2017;58(5):447–455.

Warmink K, Kozijn AE, Bobeldijk I, et al. High‐fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury. Osteoarthritis and Cartilage. 2020;28(5):593–602.

Shim SS, Leung G. Blood supply of the knee joint. Blood supply of the knee joint. A microangiographic study in children and adults. Clinical Orthopaedics and Related Research. 1986;(208):119–125.

Karakilic B, Taskiran E, Doganavsargil B, et al. Central defect type partial ACL injury model on goat knees: the effect of infrapatellar fat pad excision. Journal of Orthopaedic Surgery and Research. 2015;10:137.

Mattap SM, Aitken D, Wills K, et al. Patellar tendon enthesis abnormalities and their association with knee pain and structural abnormalities in older adults. Osteoarthritis and Cartilage. 2019;27(3):449–458.

Minatani A, Uchida K, Inoue G, et al. Activation of calcitonin generelated peptide signaling through the prostaglandin E2 EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients. Journal of Orthopaedic Surgery and Research. 2016;11(1):117.

Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988;241(4870):1218–1221.

Ansel JC, Brown JR, Payan DG, et al. Substance P selectively activates TNF‐alpha gene expression in murine mast cells. Journal of Immunology. 1993;150(10):4478–4485.

Karabucak B, Walsch H, Jou YT, et al. The role of endothelial nitric oxide in the Substance P induced vasodilation in bovine dental pulp. Jounal of Endodontics. 2005;31(10):733–736.

Aikawa J, Uchida K, Takano S, et al. Expression of calcitonin generelated peptide in the infrapatellar fat pad in knee osteoarthritis patients. Journal of Orthopaedic Surgery and Research. 2017;12(1):65.

Aikawa J, Uchida K, Takano S, et al. Regulation of calcitonin generelated peptide expression through the COX‐2/mPGES‐1/PGE2 pathway in the infrapatellar fat pad in knee osteoarthritis. Lipids in Health and Disease. 2018;17(1):215.

Haegerstrand A, Dalsgaard CJ, Jonzon B, et al. Calcitonin gene‐related peptide stimulates proliferation of human endothelial cells. Proceedings of the National Academy of Sciences (USA). 1990;87(9):3299–3303.

Onuma H, Tsuji K, Hoshino T, et al. Fibrotic changes in the infrapatellar fat pad induce new vessel formation and sensory nerve fiber endings that associate prolonged pain. Journal of Orthopaedic Research. 2020;38(6):1296–1306.

Lu M, Chen Z, Han W, et al. A novel method for assessing signal intensity within infrapatellar fat pad on MR images in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 2016;24(11):1883–1889.

Ruhdorfer A, Haniel F, Petersohn T. Between-group differences in infra-patellar fat pad size and signal in symptomatic and radiographic progression of knee osteoarthritis vs non-progressive controls and healthy knees-data from the FNIH Biomarkers Consortium Study and the Osteoarthritis Initiative. Osteoarthritis and Cartilage. 2017;25(7):1114–1121.

Pan F, Han W, Wang X, et al. A longitudinal study of the association between infrapatellar fat pad maximal area and changes in knee symptoms and structure in older adults. Annals of Rheumatic Diseases. 2015;74(10):1818–1824.

Chuckpaiwong B, Charles HC, Kraus VB, et al. Age-associated increases in the size of the infrapatellar fat pad in knee osteoarthritis as measured by 3T MRI. Journal of Orthopaedic Research. 2010;28(9):1149–1154.

Wu J, Wang K, Xu J. Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 2017;25(9):1428–1435.

Wang K, Xu J, Cai J, et al. Serum levels of interleukin-17 and adiponectin are associated with infrapatellar fat pad volume and signal intensity alteration in patients with knee osteoarthritis. Arthritis Research & Therapy. 2016;18(1):193.

Han W, Aitken D, Zheng S, et al. Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal-Intensity Alteration and Magnetic Resonance Imaging-Assessed Progression of Knee Osteoarthritis. Arthritis Care & Research. 2019;71(5):638–646.

Wang K, Ding C, Hannon MJ, et al. Signal intensity alteration within infrapatellar fat pad predicts knee replacement within 5 years: data from the Osteoarthritis Initiative. Osteoarthritis and Cartilage. 2018;26(10):1345–1350.

Han W, Aitken D, Zhu Z, et al. Hypointense signals in the infrapatellar fat pad assessed by magnetic resonance imaging are associated with knee symptoms and structure in older adults: a cohort study. Arthritis Research & Therapy. 2016;18(1):234.

Chang J, Liao Z, Lu M, et al. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis and Cartilage. 2018;26(7):864–871.

Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Archives of Medical Science. 2013;9(2):191–200.

do Amaral RJFC, Almeida HV, Kelly DJ, et al. Infrapatellar Fat Pad Stem Cells: From Developmental Biology to Cell Therapy. Stem Cells International. 2017;2017:6843727.

Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens, et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Annals of Rheumatic Diseases. 2011;70(5):851–857.

Shelbourne KD, Jari S, Gray T. Outcome of untreated traumatic articular cartilage defects of the knee: a natural history study. Journal of Bone and Joint Surgery (Am). 2003;85-A(Suppl. 2):8–16.

Murphy JM, Fink DJ, Hunziker EB, et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis & Rheumatology. 2003;48(12):3464–3474.

Lee KB, Hui JH, Song IC, et al. Injectable mesenchymal stem cell therapy for large cartilage defects–a porcine model. Stem Cells. 2007;25(11):2964–2971.

Centeno CJ, Busse D, Kisiday J, et al. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Medical Hypotheses. 2008;71(6):900–908.

Centeno CJ, Busse D, Kisiday J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343–353.

Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis and Cartilage. 2002;10(3):199–206.

Maekawa K, Furukawa H, Kanazawa Y, et al. Electron and immunoelectron microscopy on healing process of the rat anterior cruciate ligament after partial transection: the roles of multipotent fibroblasts in the synovial tissue. Histology and Histopathology. 1996;11(3):607–619.

Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902–907.

Liu Y, Buckley CT, Almeida HV, et al. Infrapatellar fat pad-derived stem cells maintain their chondrogenic capacity in disease and can be used to engineer cartilaginous grafts of clinically relevant dimensions. Tissue Engineering Part A. 2014;20(21-22):3050–3062.

Stocco E, Barbon S, Piccione M, et al. Infrapatellar Fat Pad Stem Cells Responsiveness to Microenvironment in Osteoarthritis: From Morphology to Function. Frontiers in Cell and Developmental Biology. 2019;7:323.

Pei M. Environmental preconditioning rejuvenates adult stem cells' proliferation and chondrogenic potential. Biomaterials. 2017;117:10–23.

Kouidhi M, Villageois P, Mounier CM, et al. Characterization of human knee and chin adipose-derived stromal cells. Stem Cells International. 2015;2015:592090.

Dragoo JL, Samimi B, Zhu M, et al. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. Journal of Bone and Joint Surgery (Br). 2003;85(5):740–747.

Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. Journal of Cellular Biochemistry. 1997;64(2):278–94.

van Duren BH, Lamb JN, Nisar S, et al. Preservation vs. resection of the infrapatellar fat pad during total knee arthroplasty Part I: A survey of current practice in the UK. Knee. 2019;26(2):416–421.

Yao B, Samuel LT, Acuña AJ, et al. Infrapatellar Fat Pad Resection or Preservation during Total Knee Arthroplasty: A Systematic Review. Journal of Knee Surgery. 2021;34(4):415–421.

Banks SA, Hodge WA. Implant design affects knee arthroplasty kinematics during stair-stepping. Clinical Orthopaedics and Related Research. 2004;426:187–193.

Van Beeck A, Clockaerts S, Somville J, et al. Does infrapatellar fat pad resection in total knee arthroplasty impair clinical outcome? A systematic review. Knee. 2013;20(4): 226–231.

White L, Holyoak R, Sant J, et al. The effect of infrapatellar fat pad resection on outcomes post-total knee arthroplasty: a systematic review. Archives of Orthopaedic and Trauma Surgery. 2016;136(5):701–708.

Ye C, Zhang W, Wu W, et al. Influence of the infrapatellar fat pad resection during total knee arthroplasty: a systematic review and meta-analysis. PLoS One 2016;11: e0163515.

Capkin S, Ozmanevra R, Demirkiran ND, et al. Current practices regarding the management of infrapatellar fat pad during total knee arthroplasty: A survey of orthopedic surgeons. Turkish Journal of Clinics and Laboratory. 2021;3:242–248.

Seo JG, Lee SA, Moon YW, et al. Infrapatellar fat pad preservation reduces wound complications after minimally invasive total knee arthroplasty. Archives of Orthopaedic and Trauma Surgery. 2015;135(8):1157–1162.

Fahmy M, Seifeldin AF. The impact of infrapatellar fat pad excision versus preservation after total knee replacement on anterior knee pain, functional outcome and patellar height:Randomized controlled trial. Journal of Orthopaedics. 2022;29:1–8.

Pinsornsak P, Naratrikun K, Chumchuen S. The effect of infrapatellar fat pad excision on complications after minimally invasive TKA: a randomized controlled trial. Clinical Orthopaedics and Related Research. 2014;472(2):695–701.

Meneghini RM, Pierson JL, Bagsby D, et al. The effect of retropatellar fat pad excision on patellar tendon contracture and functional outcomes after total knee arthroplasty. Journal of Arthroplasty. 2007;22(6 Suppl 2):47–50.

Tanaka N, Sakahashi H, Sato E, et al. Influence of the infrapatellar fat pad resection in a synovectomy during total knee arthroplasty in patients with rheumatoid arthritis. Journal of Arthroplasty. 200318(7):897–902.

Maculé F, Sastre S, Lasurt S, et al. Hoffa's fat pad resection in total knee arthroplasty. Acta Orthopaedica Belgica. 2005;71(6):714–717.

Koeck FX, Schmitt M, Baier C, et al. Predominance of synovial sensory nerve fibers in arthrofibrosis following total knee arthroplasty compared to osteoarthritis of the knee. Journal of Orthopaedic Surgery Research. 2016;11:25.

Nisar S, Lamb JN, Somashekar N, et al. Preservation vs. resection of the infrapatellar fat pad during total knee arthroplasty part II: A systematic review of published evidence. Knee. 2019;26(2):422–426.

Subramanyam P, Sundaram PS, Rao N. Scintigraphic assessment of patellar vascularity in total knee replacement surgeries following lateral release. Avicenna Journal of Medicine. 2012;2(3):54–59.

McMahon MS, Scuderi GR, Glashow JL, et al. Scintigraphic determination of patellar viability after excision of infrapatellar fat pad and/or lateral retinacular release in total knee arthroplasty. Clinical Orthopaedic and Related Research. 1990;(260):10–16.

İmren Y, Dedeoğlu SS, Çakar M, et al. Infrapatellar Fat Pad Excision during Total Knee Arthroplasty Did Not Alter the Patellar Tendon Length: A 5-Year Follow-Up Study. Journal of Knee Surgery. 2017;30(5):479–483.

Lemon M, Packham I, Narang K, et al. Patellar tendon length after knee arthroplasty with and without preservation of the infrapatellar fat pad. Journal of Arthroplasty. 2007;22(4):574–580.

Chougule SS, Stefanakis G, Stefan SC, et al. Effects of fat pad excision on length of the patellar tendon after total knee replacement. Journal of Orthopaedics. 2015;12(4):197–204.

Sellars H, Yewlett A, Trickett R, et al. Should we resect Hoffa’s fat pad during total knee replacement? Journal of Knee Surgery. 2017;30:894–897.

Moverley R, Williams D, Bardakos N, et al. Removal of the infrapatella fat pad during total knee arthroplasty: does it affect patient outcomes? International Orthopaedics. 2014;38(12):2483–2487.

Gelecek

13 Ekim 2022

Lisans

Lisans